Ozempic and Wegovy are no longer in shortage, FDA says
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.
F.D.A. Firings Decimated Teams Reviewing A.I. and Food Safety
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
News Medical8h
The dangers of fraudulent diabetes products and how to avoid them
As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to prevent, ...
Medscape8h
How Can Machine Learning Boost T1D Patients’ Time in Range?
The Helmsley Charitable Trust’s T1D Exercise Initiative ( T1-DEXI) datasets provide baseline information on the glycemic ...
FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Endocrinology Advisor1d
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
Ever-Growing USA on MSN2d
GlycoShield Reviews and Complaints: My Honest 30-Day Experience (2025 Update)
GlycoShield stands out as an all-natural dietary supplement designed to support overall blood sugar balance and metabolic ...
Hosted on MSN2d
Is Sug Clean Safe? What I Learned About the Ingredients & Side Effects
Maintaining optimal blood sugar levels is crucial for overall health and well-being. High or low blood sugar can lead to ...
Capital Public Radio2d
State insulin program still has no firm timeline
“Our internal and external experts all believe that the implementational time frame, while not as fast as we had hoped, are ...
Interesting Engineering2d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
HeraldNet18d
Harrop: Democrats have a winning issue: drug prices
(Under Azar, Eli Lilly tripled the price of its top-selling insulin drug ... In its last days, the Biden administration targeted another 15 Part D drugs for price negotiations.